November 2, 2026 · Pain · DOI: 10.1097/j.pain.0000000000004110

Chloride dysregulation: the next target for chronic pain therapeutics.

Listen to this summary

This review argues that chronic pain treatments have failed because they suppress normal pain signaling rather than correcting the pathological mechanisms specific to chronic pain. The author highlights injury-induced loss of the chloride transporter KCC2 in spinal dorsal horn neurons as a mechanism for inhibitory failure that can explain key neuropathic pain symptoms, and shows how chloride dysregulation produces counterintuitive effects, such as benzodiazepines potentially becoming pro-excitatory. The paper positions KCC2 as a promising therapeutic target for both analgesia and disease modification.

Yves De Koninck

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play